Treatment of Disseminated Classic Type of Kaposi’s Sarcoma with Paclitaxel
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Classic Kaposi sarcoma (KS) is a rare human herpes virus 8-associated angioproliferative disease, and the disseminated classic type of KS in Korea is even rarer. The treatment options for classic KS vary and range from surgical excision to ionizing irradiation or chemotherapy. Recently, there have been a few reports of treating classic KS with paclitaxel,which has been used to treat AIDS-associated KS and post-transplant KS. We herein report a case of disseminated classic type KS in a 78-year-old Korean male patient who showed dramatic response after only two cycles of paclitaxel treatment. (Ann Dermatol 23(4) 504∼507, 2011)
Abstract
Classic Kaposi sarcoma (KS) is a rare human herpes virus 8-associated angioproliferative disease, and the disseminated classic type of KS in Korea is even rarer. The treatment options for classic KS vary and range from surgical excision to ionizing irradiation or chemotherapy. Recently, there have been a few reports of treating classic KS with paclitaxel,which has been used to treat AIDS-associated KS and post-transplant KS. We herein report a case of disseminated classic type KS in a 78-year-old Korean male patient who showed dramatic response after only two cycles of paclitaxel treatment. (Ann Dermatol 23(4) 504∼507, 2011)
참고문헌 (18)
- Sarid R, "Virology, pathogenetic mechanisms, and associated diseases of Kaposi sarcomaassociated herpesvirus (human herpesvirus 8)", Mayo Clin Proc, 77, pp.941~949 (2002)
- Ensoli B, "Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents", Cytokine Growth Factor Rev, 9, pp.63~83 (1998)
- Kang MJ, "Recurrent classical type of Kaposi's sarcoma treated by interferon-alpha", Ann Dermatol, 20, pp.162~165 (2008)
- Sung JC, "Kaposi's sarcoma: advances in tumor biology and pharmacotherapy", Pharmacotherapy, 17, pp.670~683 (1997)
- Fenig E, "Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel", Am J Clin Oncol, 21, pp.498~500 (1998)
- Rowinsky EK, "Paclitaxel pharmacology and other tumor types", Semin Oncol, 24(6), pp.1~12 (1997)
- Schwartz RA, "Kaposi's sarcoma: an update", J Surg Oncol, 87, pp.146~151 (2004)
- 김혜원, "Paclitaxel로 치료한 면역 억제제 관련형 카포시 육종 1예", 대한피부과학회지, 43(8), pp.1119~1123 (2005), 대한피부과학회
- Iscovich J, "Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study", AIDS, 12, pp.2067~2072 (1998)
- Cattani P, "Age-specific seroprevalence of Human Herpesvirus 8 in Mediterranean regions", Clin Microbiol Infect, 9, pp.274~279 (2003)
- Levi MJ, "Classic Kaposi's sarcoma", J Am Podiatr Med Assoc, 95, pp.586~588 (2005)
- Tschachler E, "Kaposi sarcoma. In Fitzpatrick's dermatology in general medicine. 7th ed", pp.1183~1187 (2008), New York: McGrow-Hill
- Schwartz RA, "Kaposi sarcoma: a continuing conundrum", J Am Acad Dermatol, 59, pp.179~206 (2008)
- Toschi E, "Treatment of Kaposi's sarcoma--an update", Anticancer Drugs, 13, pp.977~987 (2002)
- Brambilla L, "Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases", Br J Dermatol, 158, pp.1339~1344 (2008)
- Baskan EB, "Treatment of advanced classic Kaposi's sarcoma with weekly low-dose paclitaxel therapy", Int J Dermatol, 45, pp.1441~1443 (2006)
- Sgadari C, "Mechanism of paclitaxel activity in Kaposi's sarcoma", J Immunol, 165, pp.509~517 (2000)
- Fardet L, "Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection", Cancer, 106, pp.1785~1789 (2006)